BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Jayson Punwani will moderate a discussion on Impact Investing at BIO International Convention 2013 in Chicago.
News | 04. 22. 2013
Jayson Punwani will moderate a discussion on Impact Investing at BIO International Convention 2013 in Chicago.
